SCHEMBL4358520

SCHEMBL4358520

CC(C)(C)CC(C)(C)NC(=O)N(S)c1cc(Cl)cc(Cl)c1O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C4 P17516 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
POLB P06746 2/20 0.35
ACLY P53396 4/20 0.33
ALDH1A1 P00352 4/20 0.33
CYP3A4 P08684 2/20 0.33
TSHR P16473 2/20 0.33
RECQL P46063 2/20 0.33
HSD17B10 Q99714 2/20 0.33
MAPT P10636 3/20 0.32
KDM4E B2RXH2 2/20 0.32
SLC2A1 P11166 1/20 0.32
TBXAS1 P24557 2/20 0.32
MAPK1 P28482 2/20 0.32
MAPK14 Q16539 2/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
CA1 P00915 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4350141 0.84 POLB (0.32) POLB
SCHEMBL4345693 0.83 POLB (0.37) AKR1C2AKR1C1POLBACLYALDH1A1
SCHEMBL4357522 0.82 POLB (0.33) POLBALDH1A1MAPTCA1CA2
SCHEMBL4345666 0.82 POLB (0.38) POLBALDH1A1CYP3A4MAPTKDM4E
SCHEMBL4352959 0.82 POLB (0.40) POLBALDH1A1MAPTKDM4EMAPK1
SCHEMBL4350397 0.76 POLB (0.34) POLBALDH1A1MAPTKDM4EHPGD
SCHEMBL4343914 0.75 POLB (0.32) POLB
SCHEMBL4342228 0.74 CA2 (0.42) POLBALDH1A1CYP3A4MAPTMAPK1
SCHEMBL4352229 0.74 POLB (0.38) POLBALDH1A1MAPTHPGDHTT
SCHEMBL4348736 0.74 POLB (0.39) POLBALDH1A1TSHRHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF JERINI AG (DE) 2011-03-17 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP claimed
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors JERINI AG (DE) 2007-03-08 US claimed
EP-2100876-A2 New compounds for the inhibition of rotamases and use thereof Jerini AG (DE) 2009-09-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110065760-A1 COMPOUNDS FOR THE INHIBITION OF ROTAMASES AND USE THEREOF NR1I3, NR1D1, NR1D2 AKR1C4 147/4885AKR1C3 91/4885AKR1C2 207/4885
US-20070054904-A1 Phenol derivatives and their use as rotamase inhibitors NR1I3, NR1D1, NR1D2 AKR1C4 192/4885AKR1C3 125/4885AKR1C2 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.